10TH ANNIVERSARY INTERNATIONAL CONFERENCE OF CONTEMPORARY ONCOLOGY

POZNAN, 21.03.2018 - 23.03.2018
PROGRAMME
 
21
marca
Wednesday - Day 1
Sala 1
12:00–12:30
Snacks & Drinks
12:30–14:15
SESSION 1. INTERACTIONS BETWEEN HOST AND CANCER
Chairs:
Magdalena CHECHLIŃSKA, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
Jan LUBIŃSKI, Pomeranian Medical University, Szczecin, PL
12:30–12:55
Gene - environment interactions and cancer risk
Jan LUBIŃSKI, Pomeranian Medical University, Szczecin, PL
12:55–13:20
TCGA Legacy: Multi-Omics Studies in Cancer
Maciej WIZNEROWICZ, Poznan University of Medical Sciences Medical, Poznan, PL
13:20–13:45
Molecular changes in cancer-adjacent histologically normal epithelia
Magdalena CHECHLINSKA, Mariusz KULIŃCZAK, Maria SROMEK, Grzegorz PANEK, Klara ZAKRZEWSKA,
Renata ŁATOCKA, Jan Konrad SIWICKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
13:45–14:10
The role of arginase-1 in antitumor immune response
Dominika NOWIS, Warsaw Medical University, Warsaw, PL
14:10–14:55
LUNCH
14:55–18:00
SESSION 2. BIOMARKERS
Chairs:
Theresa WHITESIDE, University of Pittsburgh Cancer Institute, PA, USA
Tomasz BURZYKOWSKI, University of Hasselt, Belgium
14:55–15:20
Potentials and pitfalls of biomarker-based adaptive-randomization in cancer trials
Tomasz BURZYKOWSKI, University of Hasselt, Belgium
15:20–15:45
Multi-parametric-monitoring predictive models of potentials and pitfalls of biomarker-based adaptive-randomization in cancer trials
Krzysztof SKŁADOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, PL
15:45–16:10
The role of the CRNDE oncogene in cancer development and screening
Łukasz SZAFRON, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
16:10–16:35
Serum microRNAs as biomarkers of high-dose irradiation
Wojciech FENDLER, Medical University of Lodz/Harvard Medical School, Boston, MA, USA
16:35–17:00
Tumor-derived exosomes as potential biomarkers of cancer progression and immune dysfunction in patients with melanoma
Theresa WHITESIDE, University of Pittsburgh Cancer Institute, PA, USA
17:00–17:25
Serum metabolomics – new approach to support early detection of lung cancer
Piotr WIDŁAK, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, PL
17:25–17:50
Circulating tumor DNA in lung cancer – clinical potential and challenges
Joanna CHOROSTOWSKA-WYNIMKO, National Institute of Tuberculosis and Lung Diseases, Warsaw, PL
17:50–18:00
Discussion
18:00–18:50
POSTER SESSION
18:50–19:50
OPENING CEREMONY AND WELCOME ADDRESS
Keynote lecture: T cell Therapy of Cancer: Green Eggs and Ham
Cassian YEE, MD Anderson Cancer Center, Houston, TX, USA
20:00
DINNER for all registered participants
22
marca
Thursday - Day 2
Room 1
9:00–11:25
SESSION 3. TUMOR MICROENVIRONMENT AND ITS TARGETING
Chairs:
Salem CHOUAIB, Institute Goustave Roussy, Paris, FR
Martyna ELAS, Cracow, PL
9:00–9:25
Redox, oximetric and vascular imaging provide insight into tumor microenvironment
Martyna ELAS, Cracow, PL
9:25–9:50
Overcoming immunosuppression in tumor microenvironment
Viktor UMANSKY, DKFZ Heidelberg, DE
9:50–10:15
Tumor and its hypoxic microenvironment, what should be the target?
Claudine KIEDA, CNRS, Orléans, FR, Military Institute of Medicine, Warsaw, PL
10:15–10:40
Repolarizing tumor infiltrating immune cells to enhance antitumor therapy
Bożena KAMIŃSKA-KACZMAREK, Nencki Institute of Experimental Biology, Warsaw, PL
10:40–11:05
Defining Landscape of Intratumoral T lymphocytes to Identify New Targets for Immunotherapy
Sergio ABRIGNANI, University of Millano, IT
10:40–11:05
Functionalized bioengineered spider silk spheres for siRNA delivery to the tumor microenvironment in cancer therapy
Hanna DAMS-KOZŁOWSKA Poznan Medical University, Poznan, PL
11:05–11:30
Presentation selected from abstracts
11:30–11:50
Coffee break
11:50–13:55
SESSION 4. CANCER IMMUNOTHERAPY – NEW APPROACHES
Chairs:
Paweł KALINSKI, Roswelt Park Memorial Institute, Buffalo, NY, USA
Helen GOGAS, National and Kapodistrian University of Athens, GR
11:50–12:15
Combinatorial Adjuvants and Dendritic Cell Therapies Sensitize Converting "Cold" Tumors to Checkpoint Blockade
Paweł KALINSKI, Roswelt Park Memorial Institute, Buffalo, NY, USA
12:15–12:40
Chimeric antigen receptor-based therapies against solid tumors - work in progress
Radosław ZAGOŻDŻON, Warsaw Medical University, Warsaw, PL
12:40–13:05
TBA
Andrzej MACKIEWICZ, Poznan University of Medical Sciences Medical, Poznan, PL
13:05–13:30
Immune regulatory cells in tumor progression
Piotr TRZONKOWSKI, Gdansk Medical University, PL
13:30–13:55
Practical aspects of metastatic melanoma treatment in Greece
Helen GOGAS
13:55–14:55
Lunch
14:55–16:45
SESSION 5. TARGETED CANCER THERAPIES
Chairs:
Piotr RUTKOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
Piotr RADZISZEWSKI, Warsaw Medical University, Warsaw, PL
14:55–15:20
How to optimize targeted therapy in gastrointestinal stromal tumors
Piotr RUTKOWSKI, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
15:20–15:55
Advanced Renal Cell Carcinoma - novel targets, new drugs
Cezary SZCZYLIK, Warsaw Medical University, Warsaw, PL
15:55–16:20
Anticoagulants in cancer patients: beyond the antithrombotic effect
Marek WOJTUKIEWICZ, Bialystok Medical University, Bialystok, PL
16:20–16:45
Is personalized treatment of prostate cancer based on biomarkers possible?
Piotr RADZISZEWSKI, Warsaw Medical University, Warsaw, PL
16:45–17:15
Coffee break
17:15–18:55
SESSION 6. CANCER CELL BIOLOGY
Chairs:
Pravin SEGHAL, New York Medical College, NY, USA
17:15–17:40
The MxA reticulum is a novel cytoplasmic organelle in cancer cells distinct from the standard reticulon-4-based endoplasmic reticulum (ER)
Pravin SEGHAL, New York Medical College, NY, USA
17:40–18:05
Significance and role of pattern recognition receptors in malignancy
Jan ŻEROMSKI, Poznan University of Medical Sciences, Poznan, PL
18:05–18:30
Goodbye flat biology - 3D cell culture models in oncology
Christian REGENBRECHT, Cellular phenomics & oncology, Berlin, DE
18:30–18:55
Presentation selected from abstracts
20:00
DINNER (TICKETED)
23
marca
Friday - Day 3
Room 1
9:00–11:35
CLINICAL SESSION 7: HAEMATOLOGICAL MALIGNANCES AS CANCER MODELS
Chairs:
Lidia GIL, Poznan University of Medical Sciences, Poznan, PL
Waldemar PRIEBE, MD Anderson Cancer Center, Houston, TX, USA
9:00–9:25
Therapy of myelodysplastic syndrome based on molecular profiling
Lidia GIL, Poznan University of Medical Sciences, Poznan, PL
9:25–9:55
Innovative therapies for lymphoma
Iwona HUS, Lublin Medical University, Lublin, PL
9:55–10:25
Targeting Therapeutically Resistant Leukemias
Waldemar PRIEBE, MD Anderson Cancer Center, Houston, TX, USA
10:25–10:50
CAR-T in plasmocytic myeloma
Andrzej JAKUBOWIAK, University of Chicago Medical Center, IL, USA
10:50–11:15
Lymphadenopathy associated with IgG4 related disease
Grzegorz DWORACKI, Dept. of Immunology, Poznań University of Medical Sciences, Poland
11:15–11:45
Coffee break
11:45–14:05
CLINICAL SESSION 8. CANCER IMMUNOTHERAPY AND COMBINATIONAL THERAPIES
Chairs:
Jacek MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL
11:45–12:10
How to increase immunotherapy efficacy of renal cell carcinoma
Jacek MACKIEWICZ, Poznan University of Medical Sciences, Poznan, PL
12:10–12:35
Real-world treatment and outcomes of metastatic cutaneous melanoma patients treated with immunotherapy in Poland
Iwona ŁUGOWSKA, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, PL
12:35–13:00
Treatment strategy in patients with metastatic colorectal cancer - new perspectives
Rafał STEC, Military Institute of Medicine, Warsaw, PL
13:00–13:25
TBA
13:25–13:50
TBA
13:50–14:30
Lunch
14:30–15:20
SESSION 9. CLINICAL
14:30–14:55
Radionuclide therapy of bone metastases - new possibilities have emerged
Rafał CZEPCZYŃSKI, Poznan University of Medical Sciences, Poznan, PL
14:55–15:20
Treatment de-escalation strategies for HPV positive head and neck cancer
Paweł GOLUSINSKI, Poznan University of Medical Sciences, Poznan, PL
15:20–17:20
SESSION 10. ORAL PRESENTATIONS FROM ABSTRACTS